U.S. President Donald Trump has increased Canadian tariffs from 25% to 35% due to alleged failures in combating drug smuggling, despite data showing minimal fentanyl seizures from Canada. Legal challenges and potential economic ramifications may lead to a reversal of the tariffs, as courts question Trump’s use of emergency powers under the IEEPA and economists warn of inflation and recession risks from the tariffs.